Masashi Kanai

Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer

Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda et al. · Journal of Clinical Oncology · 2015 · 1.2K citations

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley, Makoto Ueno, Changhoon Yoo et al. · The Lancet · 2023 · 891 citations · Full text

Urology, Surgical Oncology, Gastrointestinal Oncology +5

A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer

Masashi Kanai, Kenichi Yoshimura, Masanori Asada et al. · Cancer Chemotherapy and Pharmacology · 2010 · 391 citations

Pancreatic Cancer, Phase I/ii Study, Medicine +7

STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells

Naoki Kanda, Hiroshi Seno, Yoshitaka Konda et al. · Oncogene · 2004 · 304 citations

Tumor Biology, Gastric Cancer Cells, Oncology +12

Drastic Down-regulation of Kruppel-Like Factor 4 Expression Is Critical in Human Gastric Cancer Development and Progression

Daoyan Wei, Weida Gong, Masashi Kanai et al. · Cancer Research · 2005 · 293 citations